Quantfury Surpasses $250M in Commissions and Fees Saved for Users, Introduces New Functionality Showing Real-Time Insight Into Savings
Quantfury Trading Limited (“Quantfury”), a global multi-asset brokerage firm that has delivered trading and investing at real-time spot prices of global exchanges with zero commissions and borrowing fees since late 2018, announces the major milestone of surpassing $250 million in fees saved for its users.
With the latest version of the Quantfury app and web trading platforms, Quantfurians can now check in real time how much they have saved on fees for their open and closed trades in comparison to other widely used trading platforms globally, the likes of eToro brokerage, Binance exchange, etc.
Quantfury Trading CEO Ali Pourdad comments, “Quantfury continues to deliver unmatched conditions for trading and investing globally and now we are pleased to offer an added level of unmatched transparency.”
The total fees and commissions savings feature will also be highlighted on www.quantfury.com in real time, tracking alongside monthly volumes and the number of Quantfurians, demonstrating Quantfury’s continuing commitment to providing unmatched trading conditions and transparency for its global retail audience.
Quantfury is a global brokerage that offers commission-free trading and investing at real-time spot prices of global and crypto exchanges. Founded by a group of traders, quants and machine-learning professionals in 2017, Quantfury’s mission is to change the exploitative retail trading industry globally, making it cost-effective, fair and transparent. As of 2023, Quantfury has 400,000-plus users in more than 50 countries.
For more information, visit www.quantfury.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230122005034/en/
Gregory FCA for Quantfury
About Business Wire
24 Martin Lane
EC4R 0DR London
+44 20 7626 1982http://www.businesswire.co.uk
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ricardo Helps City of Warsaw to Introduce its First Ever Low Emission Zone28.3.2023 01:01:00 CEST | Press release
Ricardo, a global strategic environmental and engineering consulting company, has won a contract funded by the Clean Air Fund to support the City of Warsaw in Poland to assess the impacts of different Low Emission Zone (LEZ) options so that the city authority, businesses and the public has clear evidence on the costs and benefits for adopting a preferred scheme. Polish cities face severe air quality challenges. In 2018, 36 out of 50 most polluted cities in the European Union (EU) were in Poland. The country’s capital, Warsaw, is one of the most polluted cities – with exposure to air pollution having a health-related cost to society of an estimated €4.2 billion every year. It also has one of the highest vehicle ownership rates (859 per 1,000 people) in Europe and has seen a growing influx of vehicles from outside of the city. This is driven the desire by the city to introduce an ambitious Low Emission Zone in the city by 2024, but doing so in a way that does not disproportionately impac
Everen Declares $200 Million Dividend and Welcomes New Chief Operating Officer27.3.2023 22:59:00 CEST | Press release
Everen Limited (Everen) held its March 2023 Board Meeting on Tuesday, March 21st and its Annual General Meeting (AGM) on Thursday, March 23rd. During the Board Meeting, the directors approved Everen’s 2022 financial statements, discussed the ongoing execution of the 5-year Strategic Plan, and declared a dividend in the aggregate amount of $200 million payable on or before September 29, 2023 to shareholders of record on March 21, 2023. During the AGM, the Shareholders approved technical wording corrections to the Eligibility Requirements and definition of a Nuclear Facility and amended Everen’s Bye-Laws to resolve inconsistencies and elements not required by the Bermuda Companies Act 1981. They also elected a new Board of Directors who will serve for a year ending at the March 2024 AGM. The Shareholders recognized Gail Miller (VP, Human Resources) for her 18 years of service and significant contributions to the organization and also welcomed Robert Foskey into the role of Chief Operatin
Co-Founder John Keppler Rejoins Enviva Inc. as Executive Chairman of the Board27.3.2023 22:46:00 CEST | Press release
Enviva Inc. (NYSE: EVA) (“Enviva,” “our,” “we,” or the “Company”) today announced that John Keppler is returning to the Company as Executive Chairman, effective April 1, 2023. Thomas Meth will continue to lead the Company as President and Chief Executive Officer, and the Company’s interim Chairman, Ralph Alexander, will transition to the role of Lead Independent Director of the Board. Today’s announcement is consistent with the Board of Directors’ (the “Board”) governance plan as announced in November 2022, when Mr. Keppler stepped down from his role as Chairman and CEO of Enviva to address a heart condition. With Mr. Keppler’s recovery and rehabilitation following heart surgery well underway, he is returning to the Company to support his co-founding partner and CEO, Thomas Meth. As Executive Chairman, in cooperation with Mr. Meth, Mr. Keppler is expected to help drive strategic corporate initiatives, growth, and interaction with key capital markets and financial stakeholders. “I am ve
French Blood Establishment (EFS) & Brenus Pharma Partner for the GMP Production of STC-1010, an Innovative Therapy Against Colorectal Cancer27.3.2023 18:00:00 CEST | Press release
The French Blood Establishment (EFS) and Brenus Pharma announce their strategic partnership in the bioproduction of innovative therapy drugs (ITD), highlighting French expertise. This collaboration is part of a shared vision: developing the French bioproduction sector nationally and internationally. EFS’ Cell Therapy and Engineering Unit (UTICELL), based in Saint-Ismier, France, shows recognized expertise in the cell therapy field since 2003 confirmed by a European GMP Certification issued by the ANSM in 2015 for manufacturing, control and storage sites for MTIs. UTICELL also benefits from EFS’ four other certified sites’ expertise. Brenus’s proprietary platform passed key regulatory milestones in 2022 (FDA Pre-IND, EMA Scientific-Advice) and the two synergistic entities have been collaborating effectively for several months to produce GMPs batches through a first scale-up. This public-private partnership aims for a long-term perspective and will lead in 2023 to the production of clini
ETC Group Unveils New Future-Forward Global Brand27.3.2023 17:15:00 CEST | Press release
ETC Group (“ETC”), a leading global value-added distributor for the telecom network and digital infrastructure industry, announced today its intent to rebrand to Netceed. The Group’s brands will integrate into a singular organization across the globe including USTC Corp, Walker, Comstar Supply, and Multicom in the U.S.; EuroTechnoCom in France; ETCP and iETC in Portugal; Comtec in the UK, Qatar, Oman, UAE, and Hong Kong; ILDC in Israel; DNT in the Dominican Republic; ETC Morocco Networks; ETC Germany Networks; Klonex-VCS in Poland; and Tiba Produktions & Vertriebs GmbH in Austria. The unification of the Group reflects the already well-established global reach and local expertise of the companies powered by ETC Group, now coalescing them under one brand worldwide. The transition to the unified global Netceed brand is planned sequentially over six months, starting with its brands in the U.S., France, and the UK. The new name, Netceed, paired with a bold and vibrant new brand design embod